Japan, Nov. 12 -- ABBVIE INC has got intellectual property rights for 'ANTI-CCR8 ANTIBODIES.' Other related details are as follows:
Application Number: JP,2025-023976
Category (FI): C12P21/08,C12N5/10,C12N1/21,C12N1/19,C12N1/15,C12N15/63@Z,C12N15/13,C07K16/28,A61K39/395@E,A61K39/395@D,A61K39/395@T,A61K39/395@N,A61P35/00
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Feb. 18, 2025
Publication Date: May 27, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....